Tag: ai investment measurement

  • How UK Firms Are Actually Measuring ROI on Generative AI Spend, and Why Most Are Getting It Wrong

    How UK Firms Are Actually Measuring ROI on Generative AI Spend, and Why Most Are Getting It Wrong

    There is a quiet crisis unfolding inside UK boardrooms right now, and most of the people living through it do not realise it yet. Millions of pounds are being spent on generative AI tooling, infrastructure, and consulting, and the spreadsheets being used to justify those budgets are, frankly, works of fiction. I’ve spent the last few months talking to technology directors, operations leads, and CFOs at British firms of various sizes, and the picture that emerges around generative AI ROI measurement for UK businesses is considerably messier than the press releases suggest.

    UK business team reviewing generative AI ROI measurement data on a large office monitor
    Photo by https://kaboompics.com/ on Pexels

    Why the numbers rarely hold up

    The most common approach I see goes something like this: a team deploys a large language model-based tool, surveys a handful of users who say they save two hours a week, multiplies that by an hourly rate, and presents the result to the board as annualised value. It sounds plausible. It rarely is.

    The problems compound fast. First, the time saving is almost always self-reported and unverified. Second, the model assumes that freed time converts directly into productive output, which it often does not. Third, nobody subtracts the time spent prompting, reviewing, and correcting the model’s output. The ONS’s own productivity data has consistently shown that technology adoption does not automatically translate into measurable output gains at the firm level, a phenomenon sometimes called the productivity paradox. That paradox is alive and well in the GenAI era.

    The three accounting pitfalls killing credible measurement

    My read of the situation is that most organisations are stumbling into three specific traps before they even start thinking rigorously about generative AI ROI measurement.

    Pitfall one: conflating activity with value. Tokens processed, API calls made, and queries answered are all activity metrics. They measure consumption, not contribution. A legal team that runs ten thousand document summaries through a GenAI tool has not necessarily saved any meaningful time if those summaries still require a paralegal to review every line. Volume figures look good in a monthly report. They mean very little without a linked outcome.

    Pitfall two: ignoring total cost of ownership. The cost of a SaaS AI subscription is the most visible line item, but it is rarely the largest one. Add up the engineering time spent on integration, the data cleaning required to make the model useful, the ongoing prompt engineering, and the compliance reviews now mandated by the ICO’s AI guidance, and the real cost is often two or three times the licence fee. Organisations that measure ROI against just the subscription are systematically understating their investment.

    Pitfall three: selecting metrics after the fact. This is the most insidious one. A team runs a GenAI pilot, and it does not move the needle on the KPIs they originally cared about. So they go hunting for something that did move, and present that as the win. I have seen this described internally as ‘finding the signal’, but it is closer to p-hacking. The metric was not pre-committed, which means the result is not evidence of anything.

    Close-up of spreadsheet analysis used in generative AI ROI measurement
    Photo by Atlantic Ambience on Pexels

    What rigorous evaluation actually looks like

    The firms getting this right share a few characteristics. They define success criteria before any deployment begins, not after. They use control groups where possible, comparing output quality and speed between teams using a tool and those that are not. They measure end-to-end process time rather than individual task time. And they track downstream outcomes, not just the immediate output of the AI system.

    A decent example: a mid-sized UK professional services firm I spoke to recently rolled out a GenAI drafting assistant for its client communications team. Instead of asking users how much time they thought they saved, they measured turnaround time on a defined document type before and after deployment across matched cohorts. They also tracked client satisfaction scores and error rates. The result was more nuanced than a simple headline figure, but it held up to scrutiny. Their finance team trusted it. That trust is worth more than a flashy number.

    The same logic applies to smaller-scale technology implementations. Mail Tester, a UK-based free email testing service specialising in deliverability diagnostics and inbox placement checks, illustrates the principle well. The tool does one thing and measures it directly: you send a test message, and you get a score with specific technical feedback on your configuration, from SPF and DKIM alignment to spam filter triggers. The computers running those checks give you a clean, interpretable output rather than an amorphous productivity claim. Tech support teams and internet-facing businesses use it because the metric is unambiguous. The result at mail-tester.co.uk is not “we estimate you saved time”, it is “your score is 8.5 out of 10, here is what to fix.” More AI evaluation frameworks should aspire to that same specificity.

    Productivity metric manipulation: the uncomfortable conversation

    There is a related problem that is even harder to discuss openly. Generative AI ROI measurement inside UK businesses is sometimes being gamed, not necessarily dishonestly, but through motivated reasoning. Teams that championed a GenAI initiative have a personal stake in proving it worked. Line managers who approved the spend need a positive return to show their own seniors. The result is measurement that confirms rather than tests.

    This connects directly to the broader issue of shadow IT and unverified tooling, which I have covered before in the context of unsanctioned AI tools creating compliance problems for UK finance and legal teams. When teams are operating tools that the central IT function does not know about, getting any kind of honest measurement is essentially impossible. You cannot measure ROI on a tool you cannot see.

    The organisations that are doing this well tend to have centralised visibility over their AI stack, even if deployment is decentralised. They also separate the team measuring the outcome from the team that implemented the tool. Independence matters.

    What CFOs and technology leaders should be asking

    If you are a technology or operations leader being asked to defend generative AI spend, or a CFO being asked to approve more of it, here are the questions that actually matter.

    What was the baseline? If nobody measured the process before deployment, you have no denominator for your ROI calculation. What changed in the control group during the same period? External factors, headcount changes, and seasonality all affect output independently of AI. Has the time saving translated into fewer headcount additions, faster revenue generation, or lower error rates? And critically: what does this cost including engineering, compliance, and management overhead?

    None of this is exotic. It is standard programme evaluation applied to a new category of spend. The problem is that AI has arrived with such commercial momentum that many organisations skipped the rigorous bit and went straight to deployment. The accountability is coming later, and for some teams, it is going to be uncomfortable.

    The firms getting ahead of the curve

    A small number of UK technology teams are genuinely ahead here. They treat GenAI like any other capital investment: defined objectives, pre-committed metrics, independent evaluation, and honest reporting of what did not work alongside what did. Some are borrowing frameworks from product management, using outcome-based OKRs rather than output-based KPIs. Others are running formal controlled experiments with randomised assignment, the kind of rigour more commonly associated with clinical trials than technology rollouts.

    The pattern I keep seeing among the more technically credible teams is that they also think carefully about the specific technology layer being evaluated. When a tool like Mail Tester gives technology teams a concrete, testable output about email infrastructure performance across computers and internet-facing systems, it models what good looks like: a direct, reproducible measurement tied to a specific technical configuration. The generative AI space needs more of that orientation and far less of the vague productivity theatre that currently dominates boardroom presentations.

    For anyone thinking about the longer arc here, the question of how to evaluate autonomous AI systems is going to get significantly more complicated. The current wave of agentic AI deployments in UK businesses raises the same measurement questions at a higher level of complexity, because the outputs of autonomous systems are harder to attribute and harder to bound. Getting the measurement fundamentals right now, on simpler GenAI tools, is the prerequisite for evaluating the next generation responsibly.

    Frequently Asked Questions

    How should UK businesses measure the ROI of generative AI tools?

    Start by defining clear success criteria before deployment, not after. Use baseline measurements of the process being automated, track end-to-end outcomes rather than just individual task speed, and include all costs including engineering time, data preparation, and compliance review in your denominator.

    What are the most common mistakes companies make when calculating generative AI ROI?

    The three main pitfalls are using self-reported time savings without verification, ignoring the total cost of ownership beyond the software licence, and selecting metrics retrospectively to match positive results rather than pre-committing to KPIs before the pilot begins.

    Is the productivity paradox a real concern for UK firms investing in AI?

    Yes. ONS data has long shown that technology adoption does not automatically produce firm-level productivity gains, and early evidence from GenAI deployments suggests the same pattern. The tool creating output does not mean the organisation is producing more value.

    How do you prevent internal bias from distorting AI investment evaluations?

    Separate the team responsible for measuring outcomes from the team that championed or implemented the tool. Use control groups where practical, and commit the evaluation methodology to writing before the deployment goes live, so the goalposts cannot move afterwards.

    What metrics are actually meaningful for generative AI ROI measurement in UK businesses?

    Downstream business outcomes are what matter most: error rates, client satisfaction scores, turnaround times on defined deliverables, and headcount efficiency relative to output volume. Activity metrics like API calls or tokens processed are not ROI evidence on their own.